SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 515 filers reported holding SEAGEN INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,183 | -14.7% | 48,000 | -22.6% | 0.24% | +0.4% |
| Q2 2023 | $11,937 | +34.5% | 62,025 | +41.5% | 0.24% | +15.9% |
| Q1 2023 | $8,875 | +60.5% | 43,832 | +1.9% | 0.21% | +32.5% |
| Q4 2022 | $5,530 | -99.9% | 43,030 | -35.5% | 0.16% | -34.9% |
| Q3 2022 | $9,130,000 | -37.2% | 66,722 | -18.7% | 0.24% | -45.0% |
| Q2 2022 | $14,530,000 | +108.8% | 82,118 | +70.0% | 0.44% | +172.0% |
| Q1 2022 | $6,959,000 | +45.5% | 48,308 | +56.2% | 0.16% | +49.1% |
| Q4 2021 | $4,783,000 | -9.1% | 30,935 | -0.2% | 0.11% | -4.4% |
| Q3 2021 | $5,264,000 | +10.6% | 31,000 | +2.8% | 0.11% | +7.6% |
| Q2 2021 | $4,760,000 | +17.9% | 30,147 | +3.7% | 0.10% | +18.0% |
| Q1 2021 | $4,036,000 | +13.7% | 29,067 | +43.4% | 0.09% | +29.0% |
| Q4 2020 | $3,550,000 | – | 20,269 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |